These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 9692843)
1. Correlation between granulocyte/macrophage-colony-forming units and CD34+ cells in apheresis products from patients treated with different chemotherapy regimens and granulocyte-colony-stimulating factor to mobilize peripheral blood progenitor cells. Vogel W; Kunert C; Blumenstengel K; Fricke HJ; Kath R; Sayer HG; Höffken K J Cancer Res Clin Oncol; 1998; 124(6):341-5. PubMed ID: 9692843 [TBL] [Abstract][Full Text] [Related]
2. Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts. Dreger P; Klöss M; Petersen B; Haferlach T; Löffler H; Loeffler M; Schmitz N Blood; 1995 Nov; 86(10):3970-8. PubMed ID: 7579368 [TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma. Aurlien E; Holte H; Pharo A; Kvaløy S; Jakobsen E; Smeland EB; Kvalheim G Bone Marrow Transplant; 1998 May; 21(9):873-8. PubMed ID: 9613778 [TBL] [Abstract][Full Text] [Related]
4. A mononuclear cell dose of 3 x 10(8)/kg predicts early multilineage recovery in patients with malignant lymphoma treated with carmustine, etoposide, Ara-C and melphalan (BEAM) and peripheral blood progenitor cell transplantation. Smith RJ; Sweetenham JW Exp Hematol; 1995 Dec; 23(14):1581-8. PubMed ID: 8542950 [TBL] [Abstract][Full Text] [Related]
5. Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte-colony stimulating factor accelerate both neutrophil and platelet recovery after high-dose VP16, ifosfamide and cisplatin. Brugger W; Birken R; Bertz H; Hecht T; Pressler K; Frisch J; Schulz G; Mertelsmann R; Kanz L Br J Haematol; 1993 Jul; 84(3):402-7. PubMed ID: 7692928 [TBL] [Abstract][Full Text] [Related]
6. Impact of chemotherapy regimen and hematopoietic growth factor on mobilization and collection of peripheral blood stem cells in cancer patients. Nowrousian MR; Waschke S; Bojko P; Welt A; Schuett P; Ebeling P; Flasshove M; Moritz T; Schuette J; Seeber S Ann Oncol; 2003; 14 Suppl 1():i29-36. PubMed ID: 12736228 [TBL] [Abstract][Full Text] [Related]
7. Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor. Schwartzberg LS; Birch R; Hazelton B; Tauer KW; Lee P; Altemose R; George C; Blanco R; Wittlin F; Cohen J J Hematother; 1992; 1(4):317-27. PubMed ID: 1285381 [TBL] [Abstract][Full Text] [Related]
8. CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF. Cesana C; Carlo-Stella C; Regazzi E; Garau D; Sammarelli G; Caramatti C; Tabilio A; Mangoni L; Rizzoli V Bone Marrow Transplant; 1998 Mar; 21(6):561-8. PubMed ID: 9543059 [TBL] [Abstract][Full Text] [Related]
9. Clonogenic potential and phenotypic analysis of CD34+ cells mobilized by different chemotherapy regimens. Cesana C; Regazzi E; Garau D; Caramatti C; Mangoni L; Rizzoli V Haematologica; 1999 Sep; 84(9):771-8. PubMed ID: 10477448 [TBL] [Abstract][Full Text] [Related]
10. Improved priming for mobilization of and optimal timing for harvest of peripheral blood stem cells. Knudsen LM; Gaarsdal E; Jensen L; Nielsen KJ; Nikolaisen K; Johnsen HE J Hematother; 1996 Aug; 5(4):399-406. PubMed ID: 8877715 [TBL] [Abstract][Full Text] [Related]
11. Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin. Brugger W; Bross K; Frisch J; Dern P; Weber B; Mertelsmann R; Kanz L Blood; 1992 Mar; 79(5):1193-200. PubMed ID: 1371415 [TBL] [Abstract][Full Text] [Related]
12. [Study on peripheral blood stem cells mobilized by different chemotherapies with granulocyte-colony stimulating factor in ovarian cancer]. Hiura M; Murakami J; Shigemasa K; Fujioka T; Yokoyama T; Nogawa T; Chiba T; Shimokawa T Nihon Sanka Fujinka Gakkai Zasshi; 1995 Mar; 47(3):257-63. PubMed ID: 7535329 [TBL] [Abstract][Full Text] [Related]
13. Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high-dose chemotherapy. Somlo G; Sniecinski I; ter Veer A; Longmate J; Knutson G; Vuk-Pavlovic S; Bhatia R; Chow W; Leong L; Morgan R; Margolin K; Raschko J; Shibata S; Tetef M; Yen Y; Forman S; Jones D; Ashby M; Fyfe G; Hellmann S; Doroshow JH Blood; 1999 May; 93(9):2798-806. PubMed ID: 10216073 [TBL] [Abstract][Full Text] [Related]
14. Mobilization of peripheral blood progenitor cells (PBPC) through a combination of chemotherapy and G-CSF in breast cancer patients and a possibility of unprocessed whole blood collection. Vanásek J; Filip S; Medková V; Bláha M; Mericka P; Volenec K Bone Marrow Transplant; 1998 Jan; 21(2):123-6. PubMed ID: 9489627 [TBL] [Abstract][Full Text] [Related]
15. Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF. Koç ON; Gerson SL; Cooper BW; Laughlin M; Meyerson H; Kutteh L; Fox RM; Szekely EM; Tainer N; Lazarus HM J Clin Oncol; 2000 May; 18(9):1824-30. PubMed ID: 10784622 [TBL] [Abstract][Full Text] [Related]
16. Mobilizing peripheral blood stem cells with high-dose G-CSF alone is as effective as with Dexa-BEAM plus G-CSF in lymphoma patients. Kröger N; Zeller W; Fehse N; Hassan HT; Krüger W; Gutensohn K; Lölliger C; Zander AR Br J Haematol; 1998 Sep; 102(4):1101-6. PubMed ID: 9734664 [TBL] [Abstract][Full Text] [Related]
17. Release of peripheral blood progenitor cells during standard dose cyclophosphamide, epidoxorubicin, 5-fluorouracil regimen plus granulocyte colony stimulating factor for breast cancer therapy. Venturini M; Del Mastro L; Melioli G; Balleari E; Garrone O; Pasquetti W; Bason C; Ghio R; Bruzzi P; Rosso R Cancer; 1994 Oct; 74(8):2300-6. PubMed ID: 7522948 [TBL] [Abstract][Full Text] [Related]
18. Application of whole blood and peripheral blood progenitor cells (PBPC) and new strategies for rescue after intensive cyclic chemotherapy in high-risk breast cancer. Filip S; Bláha M; Odrázka K; Mericka P; Vávrová J J Hematother Stem Cell Res; 2000 Feb; 9(1):31-8. PubMed ID: 10738969 [TBL] [Abstract][Full Text] [Related]